AKT1 and colorectal carcinoma: Our results confirmed that for both CRC cells and normal colon epithelial cells, activation of Akt signaling led to increased MMP-2 and MMP-9 expression, while treatment of GL-V9 or the specific Akt inhibitor LY294002 counterbalanced the effect caused by IGF-1 (Fig. 6).